Cycle track safety remains unproven.

نویسنده

  • Paul Schimek
چکیده

Lusk et al. claim that American Association of State Highway and Transportation Officials (AASHTO) guidelines discourage " physically separated and bicycle-exclusive paths adjacent to sidewalks. " 1 In fact, these guidelines prohibit bicycle lanes on the roadway separated from travel lanes by parked cars or a raised barrier. They permit bike paths adjacent to the roadway where there is " minimal cross flow by motor vehicles. " 2 The facilities in the authors' sample that clearly contradict these AASHTO guidelines are First Avenue North in Minneapolis, Min-nesota, and First, Second, Eighth, and Ninth Avenues in New York City. Using the authors' figures, the bicycle crash rate for these facilities averages 7.0 per 10 6 kilometers traveled compared with only 0.6 per 10 6 kilometers for the remainder of the authors' sample. An explanation for the difference is that the former group averages 11.3 intersections per kilometer whereas the latter averages only 1.7 (Table 1). Lusk et al. claim that the crash rate for their sample " is low relative to reported crash rates on roadways in the United States and Canada. " However, 3 of the 4 comparison rates they cite are based on self-reports of all collisions for specific populations (bicycle messengers in Boston, MA; bicycle commuters in Toronto or Ottawa), and not on police reports of car-bicycle collisions for all bicyclists—which makes them completely inappropriate to use as a benchmark. 3-5 The 2009 National Household Transportation Survey estimates 14.413 10 6 annual kilometers of bicycle travel in the United States. 6 Dividing by the 51 000 estimated police-reported bicyclist injuries in 2009 provides a national rate of 3.5 bicycle crashes per 10 6 kilometers. 7 The facilities that are expressly prohibited by the AASHTO guidelines have a crash rate that is on average twice as high as the national average. It is premature to say this work provides additional evidence that urban cycle tracks increase bicyclist injuries attributable to intersection risk 8-10 because the authors' method does not account for confounders such as traffic speed and volume. But it is safe to conclude that this article has produced no evidence to support its claim that " bicycling on cycle tracks is safer than bicycling on roads. " j clicking the " Reprints " link. safety on bicycle paths—results from a new large scale Danish study. 2008. Letters to the editor referring to a recent Journal article are encouraged …

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Sensitivity Analysis of Fastenings’ Types on Track's Life-Cycle

During the study for the dimensioning as well as the selection of the individual materials constituting a railway track, the ballast and the substructure present residual deformations, directly related to the deterioration of the geometry of the track. The slighter the residual deformations and the slower their alteration over time is, the better the quality of the track. The actions acting ...

متن کامل

Are signalized intersections with cycle tracks safer? A case-control study based on automated surrogate safety analysis using video data.

Cities in North America have been building bicycle infrastructure, in particular cycle tracks, with the intention of promoting urban cycling and improving cyclist safety. These facilities have been built and expanded but very little research has been done to investigate the safety impacts of cycle tracks, in particular at intersections, where cyclists interact with turning motor-vehicles. Some ...

متن کامل

Cyclin D activates the Rb tumor suppressor by mono-phosphorylation

The widely accepted model of G1 cell cycle progression proposes that cyclin D:Cdk4/6 inactivates the Rb tumor suppressor during early G1 phase by progressive multi-phosphorylation, termed hypo-phosphorylation, to release E2F transcription factors. However, this model remains unproven biochemically and the biologically active form(s) of Rb remains unknown. In this study, we find that Rb is exclu...

متن کامل

Preclinical and clinical safety studies on DNA vaccines.

DNA vaccines are based on the transfer of genetic material, encoding an antigen, to the cells of the vaccine recipient. Despite high expectations of DNA vaccines as a result of promising preclinical data their clinical utility remains unproven. However, much data is gathered in preclinical and clinical studies about the safety of DNA vaccines. Here we review current knowledge about the safety o...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • American journal of public health

دوره 103 10  شماره 

صفحات  -

تاریخ انتشار 2013